Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED BALANCE SHEETS

v3.3.1.900
CONSOLIDATED BALANCE SHEETS - USD ($)
Dec. 31, 2015
Dec. 31, 2014
Current assets    
Cash $ 7,851 $ 623
Total current assets $ 7,851 623
Fixed assets - net 454
Total Assets $ 7,851 1,077
Current liabilities    
Accounts payable 622,129 484,260
Accrued interest payable 182,678 407,684
Notes payable - current - related parties 489,095 697,225
Notes payable - current, net $ 157,324 871,694
Notes payable - derivitive liability payable 25,456
Stock subscription payable $ 55,882 28,067
Related party payables 412,656 296,265
Other payables 242,612 241,922
Total current liabilities $ 2,162,376 3,052,573
Long-Term Liabilities    
Notes payable - related parties 43,298
Total Liabilities $ 2,162,376 $ 3,095,871
Stockholders' Deficit    
Preferred stock, $.00001 par value; 25,000,000 shares authorized; No shares issued and outstanding as of December 31, 2015 and December 31, 2014, respectively
Series A Convertible Preferred stock, $.00001 par value; 3,000,000 shares authorized; No shares issued and outstandingas of December 31, 2015 and December 31, 2014, respectively
Common stock, $.00001 par value; 100,000,000 shares authorized; 60,251,068 and 58,416,660 shares issued and outstanding as of December 31, 2015 and December 31, 2014, respectively $ 602 $ 585
Additional paid in capital 14,353,628 12,716,630
Accumulated deficit (16,468,956) (15,777,222)
Total Transbiotec, Inc. stockholders' deficit (2,114,726) (3,060,007)
Noncontrolling interest (39,799) (34,787)
Total Stockholders' Deficit (2,154,525) (3,094,794)
Total Liabilities and Stockholders' Deficit $ 7,851 $ 1,077